Company Financials

PTC Therapeutics, Inc. Financials

United States dollar

business PTC Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: PTCT

Market Capitalization $6.16 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 8.83
Forward PE -90.43
Price to Sales TTM $3.43
Price to Book MRQ $-38.66
Enterprise to Revenue 3.87
Enterprise to EBITDA 7.21

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 42.25%
Operating Margin 1.65%
Return on Assets TTM 25.70%
Return on Equity TTM 33.08%

Income Statement

Revenue TTM $1,779,149,952
Revenue per Share TTM $22.73
Quarterly Revenue Growth 7.20%
Gross Profit TTM $1,275,912,960
EBITDA $35,360,000
Net Income to Common TTM $751,723,008
Diluted EPS TTM $8.60
Quarterly Earnings Growth YoY 7.23%

Balance Sheet

Total Cash MRQ $1,707,309,952
Total Cash per Share MRQ $21.27
Total Debt MRQ $
Total Debt to Equity MRQ -16.00
Current Ratio MRQ 2.32
Book Value per Share MRQ $-1.95

Cash Flow

Operating Cash Flow TTM $715,465,024
Levered Free Cash Flow TTM $237,653,632

PTCT Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 79,931,766
Float Shares 70,574,223
Avg 10 Volume 1,059,520
Avg 30 Volume None
Shares Short 11,442,932
Short Ratio 5.04
Short % of Shares 16.35%
% Held by Insiders 2.45%
% Held by Institutions 105.18%

Stock Price Summary

Beta 0.47
Fifty Two Week Low $35.95
Fifty Two Week High $87.50
Fifty Two Week Change 40.34%
Day 50 MA $74.67
Day 200 MA $57.41

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date